We are live on ! Find out more
DMIC

Dixon Mitchell Investment Counsel Portfolio holdings

AUM $2.88B
1-Year Est. Return 18.53%
This Fund
S&P 500
This Quarter Est. Return
-8.53%
1 Year Est. Return
+18.53%
3 Year Est. Return
+64.59%
5 Year Est. Return
+91.01%
10 Year Est. Return
+309.92%
AUM
$577M
AUM Growth
-$70.5M
Cap. Flow
-$7.8M
Cap. Flow %
-1.35%
Top 10 Hldgs %
42.1%
Holding
70
New
3
Increased
33
Reduced
25
Closed
6

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$5.78M
2
HCA icon
HCA Healthcare
HCA
+$4.44M
3
CTSH icon
Cognizant
CTSH
+$3.71M
4
MRK icon
Merck
MRK
+$3.2M
5
AAPL icon
Apple
AAPL
+$2.21M

Sector Composition

Rank Sector Weight
1 Financials 29.2%
2 Technology 16.66%
3 Healthcare 11.78%
4 Energy 9.72%
5 Industrials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
26
HCA Healthcare
HCA
$89.5B
$7.47M 1.29%
96,565
+50,171
+108% +$4.44M
OTEX icon
27
Open Text
OTEX
$6.04B
$7.03M 1.22%
315,328
-18,012
-5% -$390K
MRK icon
28
Merck
MRK
$318B
$5.99M 1.04%
127,106
+60,313
+90% +$3.2M
UNP icon
29
Union Pacific
UNP
$174B
$5.87M 1.02%
66,445
+8,067
+14% +$736K
T icon
30
AT&T
T
$163B
$5.76M 1%
234,065
-77,079
-25% -$1.97M
BNY
31
Bank of New York Mellon
BNY
$107B
$5.58M 0.97%
142,404
+4,149
+3% +$172K
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
$5.56M 0.96%
68,643
+1,603
+2% +$140K
AXP icon
33
American Express
AXP
$230B
$5.42M 0.94%
73,145
+2,163
+3% +$166K
NVS icon
34
Novartis
NVS
$297B
$5.37M 0.93%
65,171
+1,485
+2% +$132K
CVS icon
35
CVS Health
CVS
$122B
$5.3M 0.92%
+54,977
New +$5.78M
OXY icon
36
Occidental Petroleum
OXY
$55.9B
$5.13M 0.89%
77,719
+2,408
+3% +$168K
TU icon
37
Telus
TU
$15.3B
$5.06M 0.88%
322,540
-1,412
-0.4% -$23.5K
CVX icon
38
Chevron
CVX
$366B
$4.2M 0.73%
53,225
+2,062
+4% +$174K
SJR
39
DELISTED
Shaw Communications Inc.
SJR
$3.91M 0.68%
202,926
+2,917
+1% +$59.4K
CME icon
40
CME Group
CME
$94.8B
$3.83M 0.66%
41,280
-21,465
-34% -$2.04M
MA icon
41
Mastercard
MA
$493B
$3.82M 0.66%
42,395
+429
+1% +$40.3K
CTSH icon
42
Cognizant
CTSH
$26B
$3.7M 0.64%
+59,030
New +$3.71M
MET icon
43
MetLife
MET
$62.1B
$3.5M 0.61%
83,200
+3,936
+5% +$184K
LHX icon
44
L3Harris
LHX
$53.4B
$3.45M 0.6%
47,176
-4,210
-8% -$329K
WHR icon
45
Whirlpool
WHR
$2.82B
$3.33M 0.58%
22,588
+3,649
+19% +$617K
CSX icon
46
CSX Corp
CSX
$93.1B
$3.21M 0.56%
358,365
+21,738
+6% +$213K
AGU
47
DELISTED
Agrium
AGU
$2.89M 0.5%
32,397
+434
+1% +$43.9K
MGA icon
48
Magna International
MGA
$18.8B
$2.76M 0.48%
57,839
-50,503
-47% -$2.61M
DVN icon
49
Devon Energy
DVN
$47.3B
$2.23M 0.39%
60,168
+4,271
+8% +$196K
BMO icon
50
Bank of Montreal
BMO
$127B
$2.14M 0.37%
39,445
+618
+2% +$33.9K

Similar funds

Dixon Mitchell Investment Counsel's Q3 2015 Portfolio in Review

As of Q3 2015, Dixon Mitchell Investment Counsel held 70 positions worth $577M, down 11% from $648M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Dixon Mitchell Investment Counsel's Q3 2015 filing shows 3 new, 33 increased, 25 reduced and 6 closed positions. Its largest new stake was CVS Health: 54,977 shares worth $5.3M. The largest sale was DIRECTV COM STK (DE), an estimated $5.84M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

  • Dixon Mitchell Investment Counsel's largest Q3 2015 buy was CVS Health: 54,977 shares worth $5.3M.
  • Dixon Mitchell Investment Counsel added most to HCA Healthcare in Q3 2015, an estimated $4.44M increase.
  • Dixon Mitchell Investment Counsel's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $4.07M.
  • Dixon Mitchell Investment Counsel fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $5.84M.
  • Dixon Mitchell Investment Counsel's ten largest holdings make up 42% of its $577M portfolio in Q3 2015.
  • Dixon Mitchell Investment Counsel opened 3 new positions and closed 6 in Q3 2015.
  • Dixon Mitchell Investment Counsel's portfolio value fell 11% quarter-over-quarter to $577M.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q3 2015, filed 17 Jan 2024.